Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Elite Pharmaceuticals ( (ELTP) ) is now available.
Elite Pharmaceuticals has launched a generic version of Norco®, a prominent pain management drug, potentially tapping into a lucrative market with reported annual sales of $300 million. This move underscores Elite’s strategy to focus on niche generic products, leveraging its specialized manufacturing facilities in New Jersey to produce both immediate and controlled-release oral dose medications.
For a thorough assessment of ELTP stock, go to TipRanks’ Stock Analysis page.
